(Q36693006)

15 August 2017

1 reference

title

Neurotensin agonists: potential in the treatment of schizophrenia (English)

1 reference

15 August 2017

0 references

Mona Boules

1

1 reference

15 August 2017

Amanda Shaw

series ordinal

2

1 reference

15 August 2017

Paul Fredrickson

series ordinal

3

1 reference

15 August 2017

Elliott Richelson

series ordinal

4

1 reference

15 August 2017

publication date

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

21

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

13-23

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200721010-00002

15 August 2017

exact match

0 references

cites work

The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721010-00002

Symptoms of schizophrenia. Methods, meanings, and mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721010-00002

CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721010-00002

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721010-00002

Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721010-00002

Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721010-00002

Effects of neurotensin on midbrain dopamine neurons: Are they mediated by formation of a neurotensin?dopamine complex?

21 January 2018

1 reference

12 December 2020

Reduced CSF neurotensin concentration in drug-free schizophrenic patients

1 reference

12 December 2020

Anorectic effect of calcitonin, neurotensin and bombesin infused in the area of the rostral part of the nucleus of the tractus solitarius in the rat

1 reference

12 December 2020

Endogenous neurotensin regulates hypothalamic-pituitary-adrenal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus.

1 reference

12 December 2020

Distribution of neurotensin receptors in mammalian brain. What it is telling us about its interactions with other neurotransmitter systems

1 reference

12 December 2020

Adrenal neuropeptides: regulation and interaction with ACTH and other adrenal regulators

1 reference

12 December 2020

Pro-dopamine effects of neurotensin on sensorimotor gating deficits

1 reference

12 December 2020

The neuropathology of schizophrenia

1 reference

12 December 2020

Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists.

1 reference

12 December 2020

Atypical neuroleptic-like behavioral effects of neurotensin.

1 reference

12 December 2020

The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor

1 reference

12 December 2020

Genetic analysis of the hypothalamic neurotensin system

1 reference

12 December 2020

Immunoreactive neurotensin levels in pancreas: Elevation in diabetic rats and mice

1 reference

12 December 2020

Current topics: brain penetrating neurotensin analog

1 reference

12 December 2020

Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence

1 reference

12 December 2020

Neurotensin and neurotensin receptors

1 reference

12 December 2020

CSF concentrations of neurotensin in schizophrenia: an investigation of clinical and biochemical correlates

1 reference

12 December 2020

Neurotensin in microdissected brain nuclei and in the pituitary of the lean and obese Zucker rats

1 reference

12 December 2020

Does neurotensin mediate the effects of antipsychotic drugs?

1 reference

12 December 2020

Normalization of auditory physiology by cigarette smoking in schizophrenic patients

1 reference

12 December 2020

Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol

1 reference

12 December 2020

A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity

1 reference

12 December 2020

Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats

1 reference

12 December 2020

Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line

1 reference

12 December 2020

Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects

1 reference

12 December 2020

Nicotine use in schizophrenia: the self medication hypotheses

1 reference

12 December 2020

Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.

1 reference

12 December 2020

Effects of haloperidol and risperidone on neurotensin levels in brain regions and neurotensin efflux in the ventral striatum of the rat.

1 reference

12 December 2020

Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs

1 reference

12 December 2020

Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.

1 reference

12 December 2020

Coexpression of neurotensin and c-fos mRNAs in rat neostriatal neurons following acute haloperidol

1 reference

12 December 2020

Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors

1 reference

12 December 2020

Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness

1 reference

12 December 2020

Aphagia in the rat following microinjection of neurotensin into the ventral tegmental area.

1 reference

12 December 2020

Reduced hypothalamic neurotensin concentrations in the genetically obese diabetic (ob/ob) mouse: possible relationship to obesity

1 reference

12 December 2020

[3H]Neurotensin receptor densities in human postmortem brain tissue obtained from normal and schizophrenic persons. An autoradiographic study.

1 reference

12 December 2020

Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies

1 reference

12 December 2020

Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats

1 reference

12 December 2020

Neurotensin receptors are located on dopamine-containing neurones in rat midbrain

1 reference

12 December 2020

Effects of clozapine on smoking in chronic schizophrenic outpatients

1 reference

12 December 2020

Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia

1 reference

12 December 2020

Neurotensin, schizophrenia, and antipsychotic drug action

1 reference

12 December 2020

Impaired processing of brain proneurotensin and promelanin-concentrating hormone in obese fat/fat mice

1 reference

12 December 2020

Pharmacology and biochemistry of neurotensin receptors

1 reference

12 December 2020

Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin

1 reference

12 December 2020

The Isolation of a New Hypotensive Peptide, Neurotensin, from Bovine Hypothalami

1 reference

12 December 2020

Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia

1 reference

12 December 2020

Omeprazole: short- and long-term safety

1 reference

12 December 2020

The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin

1 reference

12 December 2020

Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome

1 reference

12 December 2020

Effects of a neurotensin analogue (PD149163) and antagonist (SR142948A) on the scopolamine-induced deficits in a novel object discrimination task.

1 reference

12 December 2020

Neurotensin: central nervous system effects of a hypothalamic peptide

1 reference

12 December 2020

Animal behavior models of the mechanisms underlying antipsychotic atypicality

1 reference

12 December 2020

Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study

1 reference

12 December 2020

Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats

1 reference

12 December 2020

Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra

1 reference

12 December 2020

Stability of a novel hexapeptide, (Me)Arg-Lys-Pro-Trp-tert-Leu-Leu-OEt, with neurotensin activity, in aqueous solution and in the solid state

1 reference

12 December 2020

The effect of neurotensin on food consumption in the rat.

1 reference

12 December 2020

Mechanisms of regulation of neurotensin receptors

1 reference

12 December 2020

The effects of acute antipsychotic drug administration on the neurotensin system of the developing rat brain.

1 reference

12 December 2020

Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse.

1 reference

12 December 2020

Differential effects of antipsychotic drugs on the neurotensin concentration of discrete rat brain nuclei

1 reference

12 December 2020

Striatal injection of neurotensin increases tyrosine hydroxylase mRNA in substantia nigra

1 reference

12 December 2020

Sortilin/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking?

1 reference

12 December 2020

Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia

1 reference

12 December 2020

Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions

1 reference

12 December 2020

Neurotensin: specific binding to synaptic membranes from rat brain

1 reference

12 December 2020

Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density

1 reference

12 December 2020

Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat

1 reference

12 December 2020

Mode matches in hydrophobic free energy eigenfunctions predict peptide-protein interactions

1 reference

12 December 2020

Neurotensin modulates the binding characteristics of dopamine D2 receptors in rat striatal membranes also following treatment with toluene

1 reference

12 December 2020

Neurotensin regulation of TSH secretion in the rat

1 reference

12 December 2020

Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties

1 reference

12 December 2020

Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor

1 reference

12 December 2020

Pharmacokinetics of novel hexapeptides with neurotensin activity in rats

1 reference

12 December 2020

Serotonin, dopamine and their interactions in schizophrenia

1 reference

12 December 2020

Roles of intracellular cAMP and protein kinase A in the actions of dopamine and neurotensin on midbrain dopamine neurons

1 reference

12 December 2020

Neurotensin and dopamine interactions.

1 reference

12 December 2020

The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition

1 reference

12 December 2020

Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects

1 reference

12 December 2020

Effects of prolonged administration of neurotensin, arginine-vasopressin, NPY, and bombesin on blood TSH, T3 and T4 levels in the rat

1 reference

12 December 2020

Smoking and therapeutic response to clozapine in patients with schizophrenia

1 reference

12 December 2020

Neurotensin agonists as an alternative to antipsychotics

1 reference

12 December 2020

A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents

1 reference

12 December 2020

Chronic nicotine interactions with clozapine and risperidone and attentional function in rats

1 reference

12 December 2020

The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs

1 reference

12 December 2020

Effects of acute and subchronic administration of typical and atypical antipsychotic drugs on the neurotensin system of the rat brain

1 reference

12 December 2020

Effects of neurotensin in a rodent model of tardive dyskinesia

1 reference

12 December 2020

Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia

1 reference

12 December 2020

Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist

1 reference

12 December 2020

Bioactive analogs of neurotensin: focus on CNS effects

1 reference

12 December 2020

The neurotensin receptor: is there more than one subtype?

1 reference

12 December 2020

Electrophysiological effects of neurotensin on dopaminergic neurones of the ventral tegmental area of the rat in vitro

1 reference

12 December 2020

A placebo controlled trial of bupropion for smoking cessation in schizophrenia

1 reference

12 December 2020

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

1 reference

12 December 2020

Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine

1 reference

12 December 2020

Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE).

1 reference

12 December 2020

Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis

1 reference

12 December 2020

Neurotensin blocks certain amphetamine-induced behaviours

1 reference

12 December 2020

Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders

1 reference

12 December 2020

JMV 449: a pseudopeptide analogue of neurotensin-(8-13) with highly potent and long-lasting hypothermic and analgesic effects in the mouse

1 reference

12 December 2020

Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization

1 reference

12 December 2020

Dexfenfluramine enhances striatal dopamine release in conscious rats via a serotoninergic mechanism.

1 reference

12 December 2020

In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier

1 reference

12 December 2020

Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist

1 reference

12 December 2020

Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment

1 reference

12 December 2020

Comparison of neurotensin responses to MDL 100,907, a selective 5HT2A antagonist, with clozapine and haloperidol.

1 reference

12 December 2020

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

1 reference

12 December 2020

Neurotensin, a central nervous system peptide: apparent receptor binding in brain membranes

1 reference

12 December 2020

1 reference

12 December 2020

Effects of peripheral neurotensin on behavior of the rat

1 reference

12 December 2020

Neurotensin affects hyperactivity but not stereotypy induced by pre and post synaptic dopaminergic stimulation

1 reference

12 December 2020

Changes in the limbic neurotensin systems induced by dopaminergic drugs

1 reference

12 December 2020

Smoking and mental illness: A population-based prevalence study

1 reference

12 December 2020

Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating.

1 reference

12 December 2020

Effects of neurotensin receptor antagonism on latent inhibition in Sprague-Dawley rats

1 reference

12 December 2020

Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin

1 reference

12 December 2020

Widespread expression in adult rat forebrain of mRNA encoding high-affinity neurotensin receptor.

1 reference

12 December 2020

BMY 14802, a potential antipsychotic drug, increases expression of proneurotensin mRNA in the rat striatum.

1 reference

12 December 2020

Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802

1 reference

12 December 2020

The effects of neuropeptides on discrete-trial conditioned avoidance responding

1 reference

12 December 2020

The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia.

1 reference

12 December 2020

Theoretical insights into the mechanism of action of atypical antipsychotics.

1 reference

12 December 2020

Nicotine counteracts midbrain dopamine cell dysfunction induced by prefrontal cortex inactivation.

1 reference

12 December 2020

The effects of intra-accumbens neurotensin on sensorimotor gating

1 reference

12 December 2020

Neurotensin: an endogenous antipsychotic?

1 reference

12 December 2020

Sortilin is essential for proNGF-induced neuronal cell death

1 reference

12 December 2020

Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment

1 reference

12 December 2020

Neurotensin: effects of hypothalamic and intravenous injections on eating and drinking in rats.

1 reference

12 December 2020

The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine

1 reference

12 December 2020

Comparative antipsychotic profiles of neurotensin and a related systemically active peptide agonist

1 reference

12 December 2020

Effect of centrally administered neurotensin on multiple feeding paradigms

1 reference

12 December 2020

Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence

1 reference

12 December 2020

Comparison of mice deficient in the high- or low-affinity neurotensin receptors, Ntsr1 or Ntsr2, reveals a novel function for Ntsr2 in thermal nociception

1 reference

12 December 2020

A systemically administered neurotensin agonist blocks disruption of prepulse inhibition produced by a serotonin-2A agonist

1 reference

12 December 2020

Prolongation of clozapine-induced leukopenia with olanzapine treatment

1 reference

12 December 2020

Haloperidol rapidly increases the number of neurotensin mRNA-expressing neurons in neostriatum of the rat brain

1 reference

12 December 2020

Plasma neurotensin levels in prepubertal children and adults: possible involvement in the regulation of growth hormone secretion

1 reference

12 December 2020

Central administration of neurotensin stimulates hypothalamic-pituitary-adrenal activity. The paraventricular CRF neuron as a critical site of action

1 reference

12 December 2020

Highly potent neurotensin analog that causes hypothermia and antinociception

1 reference

12 December 2020

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia

1 reference

12 December 2020

Neurotensin analogs indications for use as potential antipsychotic compounds

1 reference

12 December 2020

Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients

1 reference

12 December 2020

10.2165/00023210-200721010-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1011618866

0 references

1 reference